News Article

In a significant move for the European healthcare distribution landscape, Palo Alto-based PE group Vivo Capital has signed a definitive agreement to acquire Dutscher Group from Paris-based PE group LBO France.

This transaction marks a major strategic expansion for Vivo Capital, representing the firm’s first-ever buyout investment in the European market.

The deal, which is expected to close during the first half of 2026, follows a five-year period of robust growth for Dutscher, which specialises in the distribution of laboratory consumables and equipment, under its previous ownership. Founded in 1982 and headquartered near Strasbourg, France, Dutscher Group has established itself as a pan-European leader in the distribution of consumables and equipment for research and development laboratories.

Dutscher operates a massive logistics network, overseeing a catalogue of more than 1 million stock-keeping units and serving a diverse client base of over 25,000 customers.

For investors and operators, the acquisition signals Vivo Capital’s intent to leverage its global ecosystem to scale Dutscher’s existing operations. Michael Chang, Managing Partner at Vivo Capital, noted that the firm plans to deepen supplier relationships globally and expand the group’s product offerings. Dutscher’s management, led by CEO Dominique Wencker, will remain involved to drive this next phase of development, which is expected to focus on both organic growth and an ambitious mergers and acquisitions strategy across Europe.

Vivo Capital manages approximately 5.8 billion dollars in assets. This acquisition underscores the firm’s commitment to the life science equipment and healthcare services sectors on a global scale.